Brief Statement FIGO Safe Motherhood and Newborn Health Committee 31 August 2012 FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage - International Federation of Gynaecology and Obstetrics - Document - PDFSEARCH.IO

First Page	Meta Content
	Brief Statement FIGO Safe Motherhood and Newborn Health Committee 31 August 2012 FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage Add to Reading List Document Date: 2014-11-17 08:17:32 Open Document File Size: 198,63 KB Share Result on Facebook Organization Royal Society of Medicine / International Federation of Gynecology and Obstetrics / World Health Organization / Brief Statement FIGO Safe Motherhood and Newborn Health Committee / / Product oxytocin / misoprostol / / PublishedMedium the Journal of the Royal Society of Medicine / / URL www.figo.org / / SocialTag Chemistry Abortifacients Gastroenterology Ketones Misoprostol Prostaglandins International Federation of Gynaecology and Obstetrics Oxytocin Obstetrics Medicine

Brief Statement FIGO Safe Motherhood and Newborn Health Committee 31 August 2012 FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhageAdd to Reading List